estrogens, conjugated (USP) 0.3 MG Oral Tablet [Premarin]
- RxCUI
- 208513
- RxNorm name
- estrogens, conjugated (USP) 0.3 MG Oral Tablet [Premarin]
- Display name
- PREMARIN (Oral Pill)
- Full name
- estrogens, conjugated (USP) 0.3 MG Oral Tablet [Premarin]
- Term type
- SBD
- Status
- Active
- Strength
- 0.3 mg
- Dose form
- Tab
- Route
- Oral Pill
- Updated
- 2026-11-08 10:19:10
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| estrogens, conjugated (USP) | 0.3 MG / 1 EACH | estrogens, conjugated (USP) | estrogens, conjugated (USP) |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| estrogens, conjugated (USP) | 4099 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Premarin 0.3 MG Oral Tablet | 1 | NAMES |
| RxNorm Name | estrogens, conjugated (USP) 0.3 MG Oral Tablet [Premarin] | 1 | NAMES |
| RxNorm Synonym | Premarin 0.3 MG Oral Tablet | 1 | NAMES |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 2 | CODES | |
| RxCUI | 208513 | 1 | CODES |
| MMSL_CODE | BD32 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0046-1100-52 | 0046-1100 | Premarin estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA004782 |
| 0046-1100-81 | 0046-1100 | Premarin estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA004782 |
| 0046-1100-91 | 0046-1100 | Premarin estrogens, conjugated | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | NDA004782 |
| 50090-1853-3 | 50090-1853 | PREMARIN estrogens, conjugated | A-S Medication Solutions | NDA004782 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Premarin | ESTROGENS, CONJUGATED | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | 258e1602-a3cf-4ccc-ca80-73dbbfb812ff | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | 0046-1100-91 0046-1100-81 0046-1100-52 0046-1100 00046110091 00046110052 00046110081 208513 |
| PREMARIN | ESTROGENS, CONJUGATED | A-S Medication Solutions | 2b4dbb7c-4e6d-47c9-b940-fef91f1f4a05 | 2024-02-04 | Boxed warning, Warnings, Adverse reactions | 50090-1853-3 50090-1853 50090185303 208513 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 2b4dbb7c-4e6d-47c9-b940-fef91f1f4a05 | PREMARIN 0.3 MG Oral Tablet [PSN] · estrogens, conjugated (USP) 0.3 MG Oral Tablet [Premarin] [SBD] · Premarin 0.3 MG Oral Tablet [SY] | 3 | 9 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) Tablets, USP for oral use Initial U.S. Approval: 1942 | 20240204 |
| b32fcb1b-fee4-44b8-a91c-10dfdd3f84ea | PREMARIN 0.3 MG Oral Tablet [PSN] · estrogens, conjugated (USP) 0.3 MG Oral Tablet [Premarin] [SBD] · Premarin 0.3 MG Oral Tablet [SY] | 3 | 3 | 20140508 | |
| 751b6213-92d8-40f8-a2d5-83e8dad086dd | PREMARIN 0.3 MG Oral Tablet [PSN] · estrogens, conjugated (USP) 0.3 MG Oral Tablet [Premarin] [SBD] · Premarin 0.3 MG Oral Tablet [SY] | 3 | 1 | PREMARIN ® (conjugated estrogens tablets, USP) | 20120718 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 258e1602-a3cf-4ccc-ca80-73dbbfb812ff | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company | 20260604 |
| 258e1602-a3cf-4ccc-ca80-73dbbfb812ff | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) tablets, for oral use Initial U.S. Approval: 1942 | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Pfizer Italia S.r.l. | Pfizer Canada ULC | Pfizer Ireland Pharmaceuticals Unlimited Company | 20260220 |
| 2b4dbb7c-4e6d-47c9-b940-fef91f1f4a05 | These highlights do not include all the information needed to use PREMARIN safely and effectively. See full prescribing information for PREMARIN. PREMARIN® (conjugated estrogens) Tablets, USP for oral use Initial U.S. Approval: 1942 | A-S Medication Solutions | 20240204 |
| b32fcb1b-fee4-44b8-a91c-10dfdd3f84ea | Physicians Total Care, Inc. | 20140508 | |
| 153b1627-0fc4-4a2a-a1ae-4e8367dcddc9 | National Council for Prescription Drug Programs | 20130213 | |
| 07343735-2a48-4eb9-ab7f-16966356238a | National Council for Prescription Drug Programs | 20120724 | |
| 0bdf0512-86bf-4352-b349-8bb3bd12dbf3 | National Council for Prescription Drug Programs | 20120724 | |
| 17eafe7b-0998-475b-a850-e5585cf18066 | National Council for Prescription Drug Programs | 20120724 | |
| 37db3830-c074-4210-a346-bedf36b5cb85 | National Council for Prescription Drug Programs | 20120724 | |
| a628176f-7fb3-489d-8c25-c3f39a7a5b8f | National Council for Prescription Drug Programs | 20120724 | |
| cce41567-13cf-4851-9e99-74fd14d1d08c | National Council for Prescription Drug Programs | 20120724 | |
| e5812917-a113-4837-86f6-23c56a71dadb | National Council for Prescription Drug Programs | 20120724 | |
| ee8b5e40-1685-4dfe-bc3d-091e86b64968 | National Council for Prescription Drug Programs | 20120724 | |
| 751b6213-92d8-40f8-a2d5-83e8dad086dd | PREMARIN ® (conjugated estrogens tablets, USP) | Aphena Pharma Solutions - Tennessee, Inc. | 20120718 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | G03CA | Natural and semisynthetic estrogens, plain | ATC1-4 | estrogens, conjugated (USP) | |
| FDASPL | D004966 | Estrogens, Conjugated (USP) | CHEM | has_chemical_structure | estrogens, conjugated (USP) |
| FDASPL | N0000175825 | Estrogen | EPC | has_epc | estrogens, conjugated (USP) |
| FDASPL | N0000000100 | Estrogen Receptor Agonists | MOA | has_moa | estrogens, conjugated (USP) |
| MEDRT | D004966 | Estrogens, Conjugated (USP) | CHEM | has_ingredient | estrogens, conjugated (USP) |
| MEDRT | D020152 | Antithrombin III Deficiency | DISEASE | ci_with | estrogens, conjugated (USP) |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | may_treat | estrogens, conjugated (USP) |
| MEDRT | D001943 | Breast Neoplasms | DISEASE | ci_with | estrogens, conjugated (USP) |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | estrogens, conjugated (USP) |
| MEDRT | D006470 | Hemorrhage | DISEASE | ci_with | estrogens, conjugated (USP) |
| MEDRT | D019584 | Hot Flashes | DISEASE | may_treat | estrogens, conjugated (USP) |
| MEDRT | D007006 | Hypogonadism | DISEASE | may_treat | estrogens, conjugated (USP) |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | estrogens, conjugated (USP) |
| MEDRT | D008594 | Menopause, Premature | DISEASE | may_treat | estrogens, conjugated (USP) |
| MEDRT | D008595 | Menorrhagia | DISEASE | may_treat | estrogens, conjugated (USP) |
| MEDRT | D009376 | Neoplasms, Hormone-Dependent | DISEASE | ci_with | estrogens, conjugated (USP) |
| MEDRT | D015663 | Osteoporosis, Postmenopausal | DISEASE | may_prevent | estrogens, conjugated (USP) |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | estrogens, conjugated (USP) |
| MEDRT | D016649 | Primary Ovarian Insufficiency | DISEASE | may_treat | estrogens, conjugated (USP) |
| MEDRT | D011471 | Prostatic Neoplasms | DISEASE | may_treat | estrogens, conjugated (USP) |
| MEDRT | D011655 | Pulmonary Embolism | DISEASE | ci_with | estrogens, conjugated (USP) |
| MEDRT | D013923 | Thromboembolism | DISEASE | ci_with | estrogens, conjugated (USP) |
| MEDRT | D013924 | Thrombophlebitis | DISEASE | ci_with | estrogens, conjugated (USP) |
| MEDRT | D020246 | Venous Thrombosis | DISEASE | ci_with | estrogens, conjugated (USP) |
| MEDRT | N0000000100 | Estrogen Receptor Agonists | MOA | has_moa | estrogens, conjugated (USP) |
| MEDRT | N0000008311 | Bone Formation Stimulation | PE | has_pe | estrogens, conjugated (USP) |
| MEDRT | N0000009051 | Gonadotropin Releasing Hormone Alteration | PE | has_pe | estrogens, conjugated (USP) |
| MEDRT | N0000009065 | Hematologic Activity Alteration | PE | ci_pe | estrogens, conjugated (USP) |
| MEDRT | N0000009805 | Pituitary Gland Activity Alteration | PE | has_pe | estrogens, conjugated (USP) |
| MEDRT | N0000009902 | Vaginal Function Alteration | PE | has_pe | estrogens, conjugated (USP) |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | estrogens, conjugated (USP) |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | estrogens, conjugated (USP) |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 0.3 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA004782 |
| NAMES | Prescribable Synonym | PREMARIN 0.3 MG Oral Tablet |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |